This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35157640
rdf:type
wikibase:Item
schema:description
научная статья artykuł naukowy tieteellinen artikkeli 2003年論文 bài báo khoa học naučni članak article scientifique (publié 2003) научни чланак vitskapeleg artikkel مقالهٔ علمی 2003年论文 2003년 논문 wissenschaftlicher Artikel wetenschappelijk artikel videnskabelig artikel (udgivet 2003) מאמר מדעי 2003年論文 article scientific 2003 թվականի հուլիսին հրատարակված գիտական հոդված 2003年论文 мақолаи илмӣ سائنسی مضمون vědecký článek artikulong pang-agham мақолаи илмӣ vitenskapelig artikkel επιστημονικό άρθρο bilimsel makale наукова стаття, опублікована в липні 2003 2003 nî lūn-bûn 2003年論文 2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած 2003年の論文 artículo científico publicado en 2003 บทความทางวิทยาศาสตร์ 2003年论文 vedecký článok scienca artikolo 2003年论文 vetenskaplig artikel artículu científicu espublizáu en 2003 articolo scientifico 2003年論文 scientific article სამეცნიერო სტატია teaduslik artikkel научна статия 2003年论文 ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tudományos cikk mokslinis straipsnis مقالة علمية 2003年論文 artigo científico научни чланак artigo científico (publicado na 2003) 2003年论文 artikull shkencor article científic artigo científico (publicado na 2003) articol științific
p:P577
wds:Q35157640-32BADDB3-A56F-488F-A152-F54745DB5EE9
wdt:P577
2003-07-01T00:00:00Z
p:P407
wds:Q35157640-B4FEA5A2-E970-4BDA-AA73-672C18F2770C
wdt:P407
wd:Q1860
p:P2860
wds:Q35157640-2C4ADB74-459E-42BF-9328-7E52313633D9 wds:Q35157640-39EAB551-9F21-40F7-98C8-4297A6E8380B wds:Q35157640-101A3662-67D3-4667-A433-DA3804ED15BF wds:Q35157640-1768149B-C99E-4EB5-8430-9C16C0884AB9 wds:Q35157640-204F6BF6-7836-46CE-9869-E44B8B0F4441 wds:Q35157640-E9278856-25D3-4C7D-9B17-AE263054AD52 wds:Q35157640-DB7152F0-0693-4E0C-A263-EFE1FA7A5150 wds:Q35157640-7086879B-91A6-4021-B47D-D54EAB609783 wds:Q35157640-75D8E1D8-998F-45D7-89D2-DC6653CD8F46 wds:Q35157640-772A75E4-8F54-4BA4-89C4-FB89FA3AAA0C wds:Q35157640-8701EE3B-B8AD-4699-A4B9-E5DD9C4183CD
wdt:P2860
wd:Q74605813 wd:Q33961645 wd:Q28377593 wd:Q41733328 wd:Q33946113 wd:Q45335490 wd:Q53602360 wd:Q50524372 wd:Q43924666 wd:Q34745427 wd:Q33891715
p:P2093
wds:Q35157640-B1C5D7B8-669E-4F8A-B6D8-B4EF1DCA25BE wds:Q35157640-3F29D429-3A22-44DF-9A4A-47DD3B8AE75A
wdt:P2093
Gerald L Andriole Roger Kirby
rdfs:label
Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia
skos:prefLabel
Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia
schema:name
Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia
p:P1476
wds:Q35157640-928E4DE3-6932-49C9-BB57-B05C33D66FCD
wdt:P1476
Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia
p:P304
wds:Q35157640-A59140F4-CE69-4544-80A1-0F4FFFB67FAD
wdt:P304
82-88
p:P31
wds:Q35157640-49365285-9d28-4283-ac6f-8c6cca3422c1 wds:Q35157640-C16BCCE5-46E1-437D-BC6E-0E5C78C86C38
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q35157640-4F59A286-DE11-40F1-8991-DB5B123CDE46
wdt:P921
wd:Q424760
p:P698
wds:Q35157640-CE54898B-9E55-4F3E-9681-4164BE9B4060
wdtn:P698
n12:12814679
wdt:P698
12814679
p:P1433
wds:Q35157640-20D1D4B4-774E-4F52-B2AA-F5790B1E90F9
wdt:P1433
wd:Q15763991
p:P433
wds:Q35157640-E52FF262-F693-4B38-8D54-1CD68E19AD2E
p:P478
wds:Q35157640-65A454FC-D3D1-4C13-964A-58B5619C5F12
wdt:P433
1
wdt:P478
44
p:P356
wds:Q35157640-16E5BB98-3513-43B6-A7A1-C311F9814BB9
wdtn:P356
n11:S0302-2838(03)00198-2
wdt:P356
10.1016/S0302-2838(03)00198-2